Synapse - Works

Results (115781)

Effects of non-linear or linear aerobic training (AT) dosing regimens on impaired cardiovascular (CV) function in patients with operable breast cancer: A randomized controlled trial (RCT)

Meeting Abstract

Scott, J.; Thomas, S. M.; Herndon, J. E.; Peppercorn, J. M.; Douglas, P. S.; Khouri, M.; Dang, C. T.; Yu, A. F.; Catalina, D.; Ciolino, C.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Ethics consultations in patients with neuro-oncologic diseases

Meeting Abstract

Sener, U.; Neil, E. C.; Carver, A.; Diamond, E. L.; Voigt, L.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL)

Meeting Abstract

Shah, B. D.; Bishop, M. R.; Oluwole, O. O.; Logan, A.; Baer, M. R.; Donnellan, W. B.; Carr-O'Dwyer, K. M.; Holmes, H.; Arellano, M. L.; Ghobadi, A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

VISION: An international, prospective, open-label, multicenter, randomized phase 3 study of (177)Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Sartor, A. O.; Morris, M. J.; Krause, B. J.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis

Meeting Abstract

Sartor, A. O.; Armstrong, A. J.; Ahaghotu, C.; McLeod, D. G.; Cooperberg, M. R.; Penson, D. F.; Kantoff, P. W.; Vogelzang, N. J.; Hussain, A.; Pieczonka, C. M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Patient-reported quality of life (QoL) of advanced melanoma patients in a phase 3 study of nivolumab (NIVO) with or without ipilimumab (IPI) versus IPI: CheckMate 067 4-year data

Meeting Abstract

Schadendorf, D.; Larkin, J. M. G.; Wolchok, J. D.; Chiarion-Sileni, V.; Taylor, F.; Lawrance, R.; Moreno-Koehler, A.; Lord-Bessen, J.; Rizzo, J. I.; Moshyk, A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

CTC versus biopsy tissue sequencing: A concordance analysis of genomic copy number profile from mCRPC patients (pts)

Meeting Abstract

Scher, H. I.; Lee, J.; Dago, A. E.; Barnett, E.; Sutton, R.; Carbone, E.; Schreiber, N. A.; Hullings, M.; Ebrahim, N.; Landers, M. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Examination of the additive value of CTC biomarkers of heterogeneity (Het) and chromosomal instability to nuclear-localized (nl) AR-V7+CTCs in prediction of poor outcomes to androgen receptor signaling inhibitor (ARSi) in metastatic castration resistant prostate cancer (mCRPC)

Meeting Abstract

Scher, H. I.; Schonhoft, J.; Graf, R. P.; Jendrisak, A.; Barnett, E.; Jayaram, A.; Winquist, E.; Landers, M.; Wang, Y.; Allan, A. L.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma

Meeting Abstract

Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Alpelisib (ALP) plus endocrine therapy (ET) in patients (pts) with PIK3CA-mutated hormone receptor-positive (HR plus ), human epidermal growth factor-2-negative (HER2-) advanced breast cancer (ABC): First interim BYLieve study results

Meeting Abstract

Rugo, H. S.; Borrego, M. R.; Chia, S. K. L.; Juric, D.; Turner, N. C.; Drullinsky, P.; Lerebours, F.; Bianchi, G. V.; Nienstedt, C. C.; Ridolfi, A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save